279 related articles for article (PubMed ID: 26318958)
1. Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population.
Sapkota B; Subramanian A; Priamvada G; Finely H; Blackett PR; Aston CE; Sanghera DK
J Diabetes Complications; 2015; 29(8):1191-7. PubMed ID: 26318958
[TBL] [Abstract][Full Text] [Related]
2. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.
El-Lebedy D; Raslan HM; Mohammed AM
Cardiovasc Diabetol; 2016 Jan; 15():12. PubMed ID: 26800892
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E E3/E4 genotype is associated with an increased risk of type 2 diabetes mellitus complicated with coronary artery disease.
Chen W; Li B; Wang H; Wei G; Chen K; Wang W; Wang S; Liu Y
BMC Cardiovasc Disord; 2024 Mar; 24(1):160. PubMed ID: 38491412
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease.
Chaudhary R; Likidlilid A; Peerapatdit T; Tresukosol D; Srisuma S; Ratanamaneechat S; Sriratanasathavorn C
Cardiovasc Diabetol; 2012 Apr; 11():36. PubMed ID: 22520940
[TBL] [Abstract][Full Text] [Related]
6. Association of adiponectin (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with Type 2 Diabetes in North Indian population of Punjab.
Matharoo K; Arora P; Bhanwer AJ
Gene; 2013 Sep; 527(1):228-34. PubMed ID: 23764562
[TBL] [Abstract][Full Text] [Related]
7. Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus.
Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
J Diabetes Complications; 2013; 27(3):255-61. PubMed ID: 23182401
[TBL] [Abstract][Full Text] [Related]
8. Association of KALRN, ADIPOQ, and FTO gene polymorphism in type 2 diabetic patients with coronary artery disease: possible predisposing markers.
Mofarrah M; Ziaee S; Pilehvar-Soltanahmadi Y; Zarghami F; Boroumand M; Zarghami N
Coron Artery Dis; 2016 Sep; 27(6):490-6. PubMed ID: 27218147
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.
Vaisi-Raygani A; Rahimi Z; Tavilani H; Pourmotabbed T
Mol Biol Rep; 2010 Apr; 37(4):2083-91. PubMed ID: 19685167
[TBL] [Abstract][Full Text] [Related]
10. The relationship of the apolipoprotein E gene polymorphism in Turkish Type 2 Diabetic Patients with and without diabetic foot ulcers.
Mehmet E; Zuhal E; Mustafa K; Soner S; Aslı T; Sevki C
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S30-3. PubMed ID: 26476487
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes.
Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; Hussain T
Mol Biol Rep; 2011 Aug; 38(6):3703-8. PubMed ID: 21400095
[TBL] [Abstract][Full Text] [Related]
13. Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction.
Ranjith N; Pegoraro RJ; Rom L; Rajput MC; Naidoo DP
Cardiovasc J S Afr; 2004; 15(3):111-7. PubMed ID: 15258620
[TBL] [Abstract][Full Text] [Related]
14. ENPP1 121Q functional variant enhances susceptibility to coronary artery disease in South Indian patients with type 2 diabetes mellitus.
Sumi S; Ramachandran S; RamanKutty V; Patel MM; Anand TN; Mullasari AS; Kartha CC
Mol Cell Biochem; 2017 Nov; 435(1-2):67-72. PubMed ID: 28497367
[TBL] [Abstract][Full Text] [Related]
15. Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus.
Ozuynuk AS; Erkan AF; Dogan N; Ekici B; Erginel-Unaltuna N; Kurmus O; Coban N
J Diabetes Complications; 2022 Jan; 36(1):108078. PubMed ID: 34686405
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E gene variants as a risk factor for coronary artery disease in type 2 diabetic Egyptian patients.
Halim EF; Reda AA; Hendi AA; Zaki SA; Essa ES; Khalifa AS
Egypt J Immunol; 2012; 19(1):1-10. PubMed ID: 23888546
[TBL] [Abstract][Full Text] [Related]
17. The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel.
Chistiakov DA; Potapov VA; Smetanina SA; Bel'chikova LN; Suplotova LA; Nosikov VV
Acta Diabetol; 2011 Sep; 48(3):227-35. PubMed ID: 21611789
[TBL] [Abstract][Full Text] [Related]
18. Association between apolipoprotein E-polymorphism and Ischemic heart disease patients with or without type 2 diabetes mellitus: a preliminary study in Kuwait.
Al-Majed HT; Qasem JA; Al-Sherifi AK; Al-Attar AA; Qasem AA; Abdullah SA
Arch Iran Med; 2011 Nov; 14(6):385-8. PubMed ID: 22039842
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.
Perron P; Brisson D; Santuré M; Blackburn P; Bergeron J; Vohl MC; Després JP; Gaudet D
J Endocrinol Invest; 2007; 30(7):551-7. PubMed ID: 17848837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
